share_log

Cowen & Co. Downgrades Cresco Labs to Market Perform, Lowers Price Target to $2.5

Cowen & Co. Downgrades Cresco Labs to Market Perform, Lowers Price Target to $2.5

Cowen & Co.将Cresco Labs的评级下调至市场表现,将目标价下调至2.5美元
Benzinga Real-time News ·  2022/12/20 21:38

Cowen & Co. analyst Vivien Azer downgrades Cresco Labs (OTC:CRLBF) from Outperform to Market Perform and lowers the price target from $7 to $2.5.

Cowen&Co.分析师Vivien Azer将Cresco Labs(场外交易代码:CRLBF)的评级从表现优于大盘下调至市场表现,并将目标价从7美元下调至2.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发